Trademarkia Logo

Canada

C$
SHERLOCK
ADVERTISED

on 10 Jan 2025

Last Applicant/ Owned by

The Broad Institute, Inc.

415 Main StreetCambridge, MA 02142

US

Serial Number

2200363 filed on 27th Jul 2022

Registration Number

TMA1282797 registered on 10th Jan 2025

Registration expiry Date

10th Jan 2035

Correspondent Address

DEETH WILLIAMS WALL LLP

150 YORK STREET, SUITE 400TORONTO

ONTARIO

CA

M5H3S5

SHERLOCK

Trademark usage description

diagnostic preparations for in vitro testing for scientific use; diagnostic preparations for medical-scientific research use; diagnostic preparations Read More

Classification Information


Class [001]
Diagnostic preparations for in vitro testing for scientific use; diagnostic preparations for medical-scientific research use; diagnostic preparations for use in assessment of genomic analysis for scientific use; reagent paper for scientific or research use


Classification kind code

11

Class [005]
RNA-guided therapeutic pharmaceutical preparations, drugs, and vaccines for the treatment of diseases and medical conditions, namely, allergies, autoimmune diseases and disorders, autoinflammatory diseases and disorders, bacterial infections, mycoses, blood diseases and disorders, cancer, cardiovascular diseases and disorders, chromosomal diseases and disorders, congenital diseases and abnormalities, hereditary diseases and abnormalities, neonatal diseases and abnormalities, cognitive diseases and disorders, connective tissue diseases and disorders, digestive system diseases and disorders, diabetes, ear, nose, and throat diseases and disorders, endocrine system diseases and disorders, female urogenital diseases and disorders, female reproductive diseases and disorders, pregnancy complications, fungal infections, genetic diseases and disorders, gastro-intestinal diseases and disorders, hemic and lymphatic diseases and disorders, hereditary cancer syndromes, heart diseases and disorders, hormonal diseases and disorders, immune system diseases and disorders, immunodeficiency diseases and disorders, infectious disease, inflammatory diseases and disorders, kidney and urinary diseases and disorders, lung diseases and disorders, male reproductive diseases and disorders, male urogenital diseases and disorders, mouth diseases and disorders, musculoskeletal diseases and disorders, neoplasms, nervous system diseases and disorders, neurological diseases and disorders, neuropsychiatric diseases and disorders, nutritional and metabolic diseases, ocular diseases and disorders, otorhinolaryngologic diseases, parasitic infections, respiratory diseases and disorders, skin and connective tissue diseases, stomatognathic diseases and disorders, chemical imbalances, viral infections.


Classification kind code

11

Class [009]
Diagnostic, examination, and monitoring equipment, namely, real-time gene amplification laboratory equipment, diagnostic biomolecule and DNA sequence readers of biomolecule and DNA sequence testing results for scientific research purposes, diagnostic biomolecule and DNA sequence detection devices for scientific research purposes, and nucleic acid sequencers for scientific purposes.


Classification kind code

11

Class [010]
Diagnostic, examination, and monitoring equipment, namely, gene testing medical apparatus for identification of genus specific and species specific DNA and RNA sequences, diagnostic biomolecule and DNA sequence detection devices for clinical medical purposes, and diagnostic biomolecule and DNA sequence readers of biomolecule and DNA sequence testing results for clinical medical use.


Classification kind code

11

Mark Details


Serial Number

2200363

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 10th Jan 2025
Registration Pending
Submitted for opposition 42
on 23rd Oct 2024
Advertised
Submitted for opposition 26
on 30th Sept 2024
Approved
Submitted for opposition 27
on 30th Sept 2024
Approval Notice Sent
Submitted for opposition 22
on 19th Jun 2023
Search Recorded
Submitted for opposition 20
on 19th Jun 2023
Examiner's First Report
Submitted for opposition 287
on 4th Aug 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 27th Jul 2022
Filed
Submitted for opposition 1
on 27th Jul 2022
Created
Submitted for opposition 31
on 27th Jul 2022
Formalized